![]() |
Volumn 277, Issue 4, 2002, Pages 2958-2964
|
Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA;
DRUG PRODUCTS;
DRUG THERAPY;
NUCLEOLAR DELOCALIZATION;
PROTEINS;
CAMPTOTHECIN DERIVATIVE;
DNA TOPOISOMERASE;
DNA TOPOISOMERASE INHIBITOR;
HYBRID PROTEIN;
MUTANT PROTEIN;
NUCLEAR PROTEIN;
PROTEIN;
SUMO PROTEIN;
TOPOTECAN;
UNCLASSIFIED DRUG;
ARTICLE;
CELLULAR DISTRIBUTION;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DRUG ACTIVITY;
DRUG TARGETING;
ENZYME LOCALIZATION;
ENZYME MODIFICATION;
HUMAN;
HUMAN CELL;
NUCLEOLUS;
PRIORITY JOURNAL;
ACTIVE TRANSPORT, CELL NUCLEUS;
ANTINEOPLASTIC AGENTS;
BLOTTING, WESTERN;
CELL NUCLEOLUS;
DNA REPAIR;
DNA TOPOISOMERASES, TYPE I;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME INHIBITORS;
GENES, DOMINANT;
HEAT;
HELA CELLS;
HUMANS;
MICROSCOPY, CONFOCAL;
MICROSCOPY, FLUORESCENCE;
MUTATION;
PLASMIDS;
RECOMBINANT FUSION PROTEINS;
SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;
TEMPERATURE;
TIME FACTORS;
TOPOTECAN;
TRANSFECTION;
|
EID: 0037169534
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M108263200 Document Type: Article |
Times cited : (98)
|
References (47)
|